Observe Change in Nasal Swab DRD2 Gene Expression in Restless Legs Syndrome (RLS) Patients on Prolonged Dopamine Agonist Treatment

Clinical trial NCT06726785 · RECRUITING

Trial details

NCT number: NCT06726785
Sponsor: HBC Immunology Inc
Status: RECRUITING
Study type: OBSERVATIONAL

Restless Leg Syndrome (RLS)

Start date: 2025-07-01
Primary completion: 2025-12-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.